Table 2. Clinical parameters of the patients.
| Parameter | Baseline (Mean ± SD) |
1 months (Mean ± SD) |
3 months (Mean ± SD) |
12 months (Mean ± SD) |
|---|---|---|---|---|
| Serum albumin (g/dL) | 3.74 ± 0.65 (3.96 ± 0.70) |
4.058 ± 0.561 | 4.14 ± 0.49 | 4.16± 0.332 |
| Serum creatinine (mg/dL) | 8.09 ± 3.54 (9.76 ± 6.33) |
1.48± 0.95 | 1.28 ± 0.36 | 1.36 ± 0.50 |
| BUN (mg/dL) | 49.62 ± 19.26 (38.57 ± 14.55) |
24.73 ± 10.303 | 21.16 ± 6.61 | 23.02 ± 8.55 |
| GFR (ml/min/1.73m2) | 9.13 ± 4.85 (10.50 ± 8.58) |
60.13 ± 21.26 | 68.15 ± 31.29 | 62.66 ± 27.343 |
| Protein/creatinine ratio UPCR (g/g) | 10.77 ± 41.44 N/A |
1.38 ± 4.72 | 2.48 ± 8.734 | 0.41 ± 0.615 |
| Total Cholesterol (mg/dL) | 159.18 ± 38.986 (139.60 ± 70.54) |
N/A | 172.29 ± 58.747 | 176.29 ± 42.338 |
| HDL (mg/dL) | 45.91 ± 12.99 (29.20 ± 15.16) |
N/A | 46.53 ± 8.5110 | 45.19 ± 14.2111 |
| LDL (mg/dL) | 76.61 ± 23.1112 (68.80 ± 47.11) |
N/A | 87.76 ± 43.5113 | 96.26 ± 30.1314 |
| Steroids (Y/N/U) |
22/7/10 (56%/18%/26%) 5/1 (83%/17%) |
|||
| Diabetes Medication (Y/N) | 3/36 (8%/92%) 0/6 (0%/100%) |
3/36 (8%/92%) | 3/35 (8%/92%) | 2/32 (6%/94%) |
| Lipid medication (Y/N) | 9/30 (23%/77%) 1/5 (17%/83%) |
9/30 (23%/77%) | 8/30 (21%/79%) | 8/26 (24%/76%) |
| Antihypertensive medication (Y/N) | 35/4 (90%/10%) 6/0 (100%/0%) |
35/4 (90%/10%) | 32/6 (84%/16%) | 28/6 (82%/18%) |
| Graft survival at 1 year | 100% | 100% | 100% | 100% |
N = 45 for clinical parameters at baseline, with N = 39 enrolled in this study, N = 6 enrolled in a previous study[5]. N = 39 for clinical parameters at 1, 3 and 12 months.
1N = 38,
2N = 38,
3N = 38,
4N = 37,
5N = 38,
6N = 34,
7N = 17,
8N = 31,
9N = 34,
10N = 17,
11N = 31,
12N = 34,
13N = 17,
14N = 31.
Y = yes, N = no, U = unknown.